Spero Therapeutics Inc.

NASDAQ: SPRO · Real-Time Price · USD
1.93
-0.05 (-2.53%)
At close: Aug 15, 2025, 3:59 PM
2.00
3.90%
After-hours: Aug 15, 2025, 06:03 PM EDT

Spero Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.81 3.40 -1.4 -5.51
PEG Ratio
0.00 -0.03 0.02 0.32
PS Ratio
2.03 0.80 1.34 27.09
PB Ratio
1.21 0.72 0.86 5.60
P/FCF Ratio
-2.37 -2.35 -8.41 -7.69
P/OCF Ratio
-2.37 -2.35 -8.41 -7.69
OCF/S Ratio
-0.86 -0.34 -0.16 -3.52
Debt / Equity Ratio
0.09 0.05 0.09 0.63
Quick Ratio
2.19 3.53 5.25 8.46
Current Ratio
2.19 3.53 5.04 8.46
Asset Turnover
0.25 0.53 0.39 0.11
Interest Coverage
n/a n/a -16.2 -45.35
Return on Equity
-1.49 0.21 -0.61 -1.02
Return on Assets
-0.62 0.13 -0.37 -0.52
Return on Invested Capital
-1.16 0.13 -0.41 -0.58
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 0.12 0.94
Net Profit Margin
-2.5 0.24 -0.96 -4.92
Pretax Profit Margin
-2.5 0.26 -0.96 -4.92
Operating Profit Margin
-2.68 0.22 -0.87 -4.82
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-2.65 0.27 -0.87 -4.77